Published in Am J Cardiol on August 01, 2000
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT | NCT00156728
Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart (2003) 0.95
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study). Am J Cardiol (2009) 0.90
Are there sex-related differences in specialized, multidisciplinary congestive heart failure clinics? Can J Cardiol (2007) 0.86
Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J (2005) 0.84
Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure. Int J Mol Imaging (2012) 0.75
Low serum triglyceride levels as predictors of cardiac death in heart failure patients. Tex Heart Inst J (2013) 0.75
Transesophageal pacing. Pacing Clin Electrophysiol (1990) 8.76
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol (2001) 4.07
Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci (Lond) (1995) 2.92
A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med (1998) 2.42
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19
Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J (2001) 2.07
[Cardiologists and limitations of statins reimbursement]. Ital Heart J Suppl (2000) 2.03
Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation (1997) 2.03
[Debate on chronic cardiopathy]. G Ital Cardiol (1992) 2.01
Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation (1997) 1.97
Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol (2000) 1.86
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia (2012) 1.85
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area. Circulation (1994) 1.68
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J (1999) 1.65
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators. Eur Heart J (1998) 1.56
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data. Eur Heart J (2002) 1.48
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol (2001) 1.47
Iron lung versus conventional mechanical ventilation in acute exacerbation of COPD. Eur Respir J (2004) 1.47
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45
Negative pressure ventilation versus conventional mechanical ventilation in the treatment of acute respiratory failure in COPD patients. Eur Respir J (1998) 1.44
Concomitant factors of decompensation in chronic heart failure. Am J Cardiol (1996) 1.42
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Evidence-based therapeutic strategies. There is the need to bridge the gap between simplified megatrials and individual prescriptions. Ital Heart J (2001) 1.40
[The history of the SET-UP study (or how difficult is neutrality in clinical research)]. Ital Heart J Suppl (2000) 1.40
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. Catheter Cardiovasc Interv (2005) 1.39
[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type]. Ital Heart J Suppl (2000) 1.39
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med (1977) 1.38
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J (1999) 1.36
Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids (2001) 1.27
In vivo ultrasound assessment of respiratory function of abdominal muscles in normal subjects. Eur Respir J (1997) 1.24
Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation (1996) 1.22
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab (2012) 1.19
Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J (1999) 1.17
Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. Am Heart J (2001) 1.17
Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol (2001) 1.16
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14
Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol (1990) 1.13
Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation (1997) 1.13
Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2007) 1.11
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
Transversus abdominis muscle function in humans. J Appl Physiol (1985) (1990) 1.05
Sympathovagal interaction during mental stress. A study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation (1991) 1.03
Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart (2002) 1.02
Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart (2002) 1.02
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02
Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. G Ital Cardiol (1998) 1.01
Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol (1998) 1.01
Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Arch Intern Med (1997) 0.99
Control of breathing in patients with severe hypothyroidism. Am J Med (1993) 0.99
Respiratory intermediate care units: a European survey. Eur Respir J (2002) 0.99
Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation (1997) 0.99
Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol (1996) 0.98
Control of breathing in patients with neuromuscular diseases. Monaldi Arch Chest Dis (1993) 0.97
Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol (1994) 0.97
Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur Respir J (1994) 0.96
Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol (1998) 0.96
Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study. Ital Heart J (2000) 0.95
Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation (1994) 0.95
Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart (2003) 0.95